Navigation Links
Red Nucleus Opens Japan Office

Red Nucleus, a leading provider of strategic learning, performance, and process solutions for the life sciences industry, today announced the opening of a new office in Tokyo, Japan. The new office will be headed by Kenji Nagamura, Associate Partner, Red Nucleus R&D.

Red Nucleus announced the new office in response to customer requests for regional coverage. Customers headquartered in Japan and global customers with Japanese affiliates have interacted with the Red Nucleus team in other regions and are looking for similar support in Japan.

Ian Kelly, Red Nucleus CEO, stated, “The opening of the Tokyo office is an exciting development for us. We are witnessing a burgeoning demand for services in Japan from our global clients. With Kenji’s leadership, we can offer direct access to the expertise and knowledge of a respected industry veteran. Kenji’s deep knowledge of Japanese regulations and business practices will help us to expand quickly and fully support our global customer base. We are looking forward to delivering the same level of support that our clients have come to expect in other regions.”

Mr. Nagamura brings over 30 years of substantial experience in regulatory strategy and operations, non-clinical and clinical to his role. He has fostered good relationships with Japan PMDA and led cross-functional and interregional teams in the implementation of Regulatory Information Management systems, Global Electronic Document Management systems, and eCTD Publishing systems. He is also experienced in developing and maintaining IDMP data submission readiness programs.

Kenji Nagamura, Red Nucleus R&D Associate Partner, added, “I am excited to represent Red Nucleus R&D in Japan. We are already planning some local executive briefings that will provide significant value to our local customers and help them to shape their R&D operational strategies in the coming year.”

The new office location is:
Shinagawa East One Tower 4F
2-16-1 Konan, Minato-ku, Tokyo
108-0075, Japan

About Red Nucleus
Red Nucleus is the premier provider of strategic learning, performance, and process solutions exclusively for the life sciences industry. Our global solutions engage and inspire teams across the commercial and R&D spaces and are designed to boost understanding, efficacy, and compliance.

Squarely focused on the life sciences industry for more than 25 years, Red Nucleus takes pride in our long-term relationships with industry leaders, as well as our strategic partnerships with innovative startups. We are focused on developing thoughtful, high-quality solutions that are in accordance with each client’s unique culture and process. Our clients trust us to build impactful, award-winning programs that deliver actionable insights and measurable results.
Visit to learn more.

Read the full story at

Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved

Related biology technology :

1. Registration Opens Today for ASGCT's 23rd Annual Meeting in Boston
2. VetStem Regenerative Cell Therapy Proponent, Dr. Kim Carlson, Opens New Surgical Practice in San Mateo California
3. MabPlex International, Ltd. Opens New Phase III and Commercial Manufacturing Facility
4. First Universal Childhood Cancer Data Lab Opens August 1, 2017
5. RMC Pharmaceutical Solutions, Inc. Opens New RTP Regional Office in North Carolina, Timothy Reinhardt to Lead the Site
6. Science Center Celebrating Immigrant Entrepreneurs; Call for Nominations Opens for Innovators Walk of Fame
7. New Optical Nanosensor Improves Brain Mapping Accuracy, Opens Way for Broader Range of Applications
8. Hair Fairies Opens Newest Salon in Atlanta
9. Foundation for Food and Agriculture Research Opens Seeding Solutions Funding Opportunity: $7 Million Available for Bold Science Addressing Food and Agriculture Challenges
10. Opentrons Opens Up Biology Laboratory Automation Platform with New API
11. OpenSGI Rebrands as BigBear, Inc. and Releases New Data Solution Platform
Post Your Comments:
(Date:7/31/2020)... ... ... R3 Stem Cell International is now offering patients the opportunity to receive ... patients may choose which extremities they would like treated. , Several studies have shown ... At R3 International, umbilical cord tissue is obtained from a lab with a long ...
(Date:7/31/2020)... ... July 29, 2020 , ... Editas Medicine, Inc. ... of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and ... a strategic partnership whereby Catalent will provide support for the development, manufacturing, and ...
(Date:7/22/2020)... ... , ... Join experts from Reed Tech , Gary Saner, Sr. Manager, ... hour live webinar on Thursday, August 13, 2020 at 11am EDT (4pm ... devices. Specifically, for medical devices, the NMPA has departments dealing with medical device registration ...
(Date:7/18/2020)... ... July 17, 2020 , ... ... firm for the life sciences and food industries, is pleased to announce that ... Clinical Research – Business Development. , Charles is an accomplished and results-driven sales ...
Breaking Biology Technology:
(Date:8/26/2020)... ... August 25, 2020 , ... Modality Solutions, ... magazine’s 2020 annual Inc. 5000 list. The list is the most prestigious ranking of ... as well, and for this year’s list, reported three-year revenue growth of 71 percent. ...
(Date:8/21/2020)... ... 2020 , ... NDA Partners Chairman Carl Peck, MD ... expertise in clinical trial planning and feasibility, regulatory inspection readiness, and clinical investigator ... career, Mr. Movahhed has helped design and manage oncology, neurology, cardiovascular, and anti-infective ...
(Date:8/5/2020)... PENSACOLA, Fla. (PRWEB) , ... August 05, 2020 , ... ... to cover two new innovations, CoreText™ and ProText™, making them the first Wharton’s jelly ... a defect using a syringe. The company’s solutions are the first Wharton’s jelly allograft ...
Breaking Biology News(10 mins):